Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06503874 · ClinicalTrials.gov registry record · NA

Improving Attention in Individuals With Long COVID-19

A NA study of Long COVID, sponsored by Shirley Ryan AbilityLab.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06503874 is a NA study of Long COVID that is actively recruiting participants, run by Shirley Ryan AbilityLab. The registered enrollment target is 60 participants, below the 2,187-participant average among 50 other Long COVID trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06503874, a NA study of Long COVID, is actively recruiting participants, sponsored by Shirley Ryan AbilityLab.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This study is to find out if the Attention Processing Training program is a potential treatment for brain fog symptoms, reported by people with Long-Covid. Also investigating the feasibility of completing this program virtually.

Conditions Studied

Long COVID

Interventions

  • OTHER Attention Training
  • OTHER Music Group

Study Locations (1)

Illinois

  • Shirley Ryan AbilityLab - Chicago

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-03-22
Est. Completion 2027-03-01
Phase NA

Sponsor

Shirley Ryan AbilityLab

138 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06503874

The ClinicalTrials.gov registry entry for NCT06503874 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,187-participant average among 50 other Long COVID trials with a reported enrollment target (97% lower). The listed sponsor is Shirley Ryan AbilityLab, which has 138 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Long COVID appearing as the primary indexed condition, and to 2 interventions - of which Attention Training is the first listed.

NCT06503874 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT06503874 about?

NCT06503874 is a clinical study titled "Improving Attention in Individuals With Long COVID-19". This study is to find out if the Attention Processing Training program is a potential treatment for brain fog symptoms, reported by people with Long-Covid. Also investigating the feasibility of completing this program virtually.

What is the current status of trial NCT06503874?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-03-22. Estimated completion is 2027-03-01.

What conditions does trial NCT06503874 study?

This clinical trial studies the following conditions: Long COVID.

What interventions are being tested in trial NCT06503874?

The interventions under investigation include: Attention Training (OTHER), Music Group (OTHER).

Who is sponsoring clinical trial NCT06503874?

This trial is sponsored by Shirley Ryan AbilityLab, which has 138 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06503874 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Long COVID

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Long COVID

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.